Purpose To investigate the outcomes of radiofrequency ablation (RFA) following artificial
ascites (AA) and artificial pleural effusion (AP) creation for hepatocellular carcinoma (HCC) …

Aim To compare the long-term local control of hepatocellular carcinoma (HCC) and risk of
peritoneal seeding via percutaneous radiofrequency ablation (RFA) using artificial ascites …

The artificial ascites technique is often used during radiofrequency ablation (RFA) for
hepatocellular carcinoma (HCC) treatment because it prevents visceral damage and …

Background Ultrasound-guided procedures are sometimes of limited use because the tumor
is located under the diaphragm or near the surface of the liver. We investigated the safety …

Results The total local recurrence rates at 1 and 2 years were 4% and 22%, respectively.
The estimated survival rates of 32 naïve patients at 1 and 3 years were 90% and 78 …

The purpose of this study was to assess the feasibility, safety and efficacy of radiofrequency
ablation (RFA) with the use of artificial ascites for hepatocellular carcinoma (HCC) adjacent …

Hepatocellular carcinoma (HCC) is the second leading cause of cancer death worldwide.
Curative treatments for early-stage HCC include local ablation, hepatic resection, and liver …

Aim To evaluate the technical feasibility of artificial ascites formation using an angiosheath
before percutaneous radiofrequency ablation (RFA) for hepatic tumours and to determine …

Background The challenge for radiofrequency ablation (RFA) of hepatocellular carcinomas
(HCC) in problematic locations is that the outcome is limited due to insufficient ablation or …

Background Repeat hepatectomy and radiofrequency ablation (RFA) are widely used to
treat early recurrent hepatocellular carcinoma (RHCC) located in the subcapsular region …